Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.

Cited by papers we hold 6

• TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action · 2017
  No notice
• Emerging and Novel Functions of Complement Protein C1q · 2015
  No notice
• Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators · 2015
  No notice
• Interleukin 12: still a promising candidate for tumor immunotherapy? · 2014
  No notice
• Tim-3: An Activation Marker and Activation Limiter of Innate Immune Cells · 2013
  No notice
• A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.